MoneyWorks4Me

The revenue for the September 2022 quarter is pegged at Rs. 13544.20 millions, about 12.71% up against Rs. 12017.10 millions recorded during the year-ago period.Profit after tax improved marginally to Rs. 1464.40  millions for the quarter ended September 2022 from Rs. 1431.30 millions of corresponding previous quarter.Operating profit for the quarter ended September 2022 rose to 2457.60 millions as compared to 2352.20 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 13544.20 12017.10 12.71 25147.50 24714.00 1.75 49966.00 50514.40 -1.09
Other Income 4.60 196.10 -97.65 10.80 237.70 -95.46 499.80 835.20 -40.16
PBIDT 2457.60 2352.20 4.48 3730.10 5139.30 -27.42 11044.30 15819.70 -30.19
Interest 119.60 45.10 165.19 206.60 65.40 215.90 166.70 127.70 30.54
PBDT 2338.00 2307.10 1.34 3523.50 5073.90 -30.56 10877.60 15692.00 -30.68
Depreciation 668.00 542.20 23.20 1128.90 977.10 15.54 1793.10 1526.00 17.50
PBT 1670.00 1764.90 -5.38 2394.60 4096.80 -41.55 9084.50 14166.00 -35.87
TAX 205.60 333.60 -38.37 205.60 738.60 -72.16 1144.50 2412.10 -52.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1464.40 1431.30 2.31 2189.00 3358.20 -34.82 7940.00 11753.90 -32.45
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 18.15 19.57 -7.30 14.83 20.80 -28.67 22.10 31.32 -29.42
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..